It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
In each of these dogs they separated their stomachs from the oesophagus and duodenum to form a pouch that drained to the body surface
In women , particularly those with polycystic ovary syndrome (PCOS), the picture is different
Heme iron polypeptides: Derived from animal hemoglobin, absorbed through a different pathway (heme carrier protein 1) than nonheme iron
The principal therapeutic action of hydrocodone is analgesia
We knew that healthy people without COVID-19 above the age of 60 years tend to be glutathione-deficient and have elevated oxidative stress
